Uses
PKN3-IN-1 (compound 16) inhibits PKN3 (serine/threonine protein kinase 3) and GAK (cyclin G-associated kinase) with IC50 of 0.014 μM and Ki of 0.0044 μM respectively. PKN3-IN-1 is a potential tool compound to study the cell biology of PKN3 and its role in pancreatic and prostate cancer and T-cell acute lymphoblastic leukemia [1].
References
[1] Asquith CRM, et al. Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype. ChemMedChem. 2022 Jun 20;17(12):e202200161. DOI:
10.1002/cmdc.202200161[2] Asquith CRM, et al. Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase. ChemMedChem. 2018 Jan 8;13(1):48-66.
[3] DR. CHRISTOPHER R. M. ASQUITH. Design and Analysis of the 4-Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure-Activity Relationships[J]. ChemMedChem, 2019, 15 1: 26-49. DOI:
10.1002/cmdc.201900521[4] SIRLE SAUL . Potent antiviral activity of novel multi-substituted 4-anilinoquin(az)olines[J]. Bioorganic & Medicinal Chemistry Letters, 2020, 30 16: Article 127284. DOI:
10.1016/j.bmcl.2020.127284